Inhibition of prolactin release by metergoline administration in man.
Oral administration of metergoline, an antiserotoninergic agent, produced a fall in plasma prolactin concentrations in normal subjects. Prolactin values remained suppressed during a five day course of treatment with the drug. Serum growth hormone values were not altered significantly.
D000328:Adult; D001971:Bromocriptine; D004873:Ergolines; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007700:Kinetics; D008297:Male; D008711:Metergoline; D011388:Prolactin / Q000097:blood*; D013997:Time Factors
D004873:Ergolines; D008711:Metergoline; D001971:Bromocriptine; D011388:Prolactin; D013006:Growth Hormone